Zymeworks Expands Pipeline Amid Modest Revenue Growth, Faces Investor Caution
Zymeworks Inc is expanding its pipeline despite modest revenue growth, but its financials paint a mixed picture, contrasting with BeiGene’s strong sales and profitability.
3 minutes to read